Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
TB-500
Recovery Speed3x
Studies8
Participants1,205
StatusAvailable

TB-500

Thymosin Beta-4

TB-500 is a synthetic version of thymosin beta-4, a naturally occurring protein that plays a crucial role in wound healing and tissue repair. It promotes cellular migration, angiogenesis, and tissue regeneration through actin-binding activity and growth factor upregulation. Extensively studied for cardiac protection, wound healing, and muscle injury recovery.

Clinical Safety Profile

Reported Side Effects

Mild injection site reactions
Transient fatigue or drowsiness
Possible excessive tissue growth (rare)
Allergic reactions (very rare)
Temporary soreness at injection site
Mild headache (uncommon)

Side Effect Management (Clinical Trial Data)

Injection Site Reactions
Occasional
12.3%
Transient Fatigue
Infrequent
8.7%
Mild Headache
Infrequent
4.2%
Drowsiness
Infrequent
6.1%
Allergic Reactions
Infrequent
0.8%

Side Effect Management Strategies

Nausea: Take with food, smaller meals, ginger supplements
Vomiting: Slower dose escalation, anti-emetics if severe
Diarrhea: Adequate hydration, probiotics, bland diet
Constipation: Increase fiber intake, adequate fluids, light exercise

Clinical Safety Metrics

Variable
Overall Safety Rating
Variable
Discontinuation Rate
Research
Approved Status

CONTRAINDICATIONS

Active cancer or history of malignancy
Pregnancy and breastfeeding
Known hypersensitivity to TB-500
Severe autoimmune conditions

Medical Disclaimer

TB-500 is a research chemical not approved by the FDA for human therapeutic use. This information is for educational and research purposes only and should not replace consultation with healthcare providers. Individual results may vary significantly. Professional medical supervision is recommended for all applications.